Date Approved

2014

Date Posted

2-11-2015

Degree Type

Campus Only Senior Honors Thesis

Department

Nursing

Second Advisor

Sandra Nelson

Abstract

Cystic Fibrosis is a chronic debilitating disease that affects approximately 70,000 individuals throughout the world. It was discovered in 1989 that the genetic disorder is caused by a mutation in the gene called the CF transmembrane conductance regulator (CFTR). Due to this mutation, the body produces an excess of thick, sticky mucus that only clogs the lungs making breathing difficult, it also obstructs the pancreas blocking enzymes from assisting in the natural breakdown of food and absorption. The purpose of this paper is to determine the importance of genetic specific medication in patients with Cystic Fibrosis in relation to an improvement in the quality of life.

Share

COinS